Carlotta Giani

2.3k total citations
50 papers, 1.5k citations indexed

About

Carlotta Giani is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, Carlotta Giani has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Surgery and 10 papers in Oncology. Recurrent topics in Carlotta Giani's work include Thyroid Cancer Diagnosis and Treatment (34 papers), Thyroid Disorders and Treatments (12 papers) and Thyroid and Parathyroid Surgery (8 papers). Carlotta Giani is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (34 papers), Thyroid Disorders and Treatments (12 papers) and Thyroid and Parathyroid Surgery (8 papers). Carlotta Giani collaborates with scholars based in Italy, United States and United Kingdom. Carlotta Giani's co-authors include Aldo Pinchera, Rossella Elisei, Eleonora Molinaro, David Viola, Laura Agate, Laura Valerio, L Baschieri, Antonio Matrone, L. Grasso and Valeria Bottici and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Carlotta Giani

50 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlotta Giani Italy 24 1.2k 312 310 290 205 50 1.5k
Junko Akaishi Japan 22 1.1k 0.9× 291 0.9× 520 1.7× 262 0.9× 290 1.4× 58 1.5k
Elham Khanafshar United States 21 973 0.8× 377 1.2× 529 1.7× 330 1.1× 292 1.4× 48 1.6k
Hyeyeun Lim United States 9 1.3k 1.0× 351 1.1× 496 1.6× 305 1.1× 253 1.2× 19 1.7k
A.-F. Cailleux France 10 882 0.7× 289 0.9× 419 1.4× 162 0.6× 157 0.8× 17 1.3k
Mitsuji Nagahama Japan 25 1.7k 1.4× 374 1.2× 909 2.9× 359 1.2× 241 1.2× 85 2.1k
Daria Handkiewicz-Junak Poland 22 1.2k 0.9× 324 1.0× 539 1.7× 194 0.7× 226 1.1× 69 1.7k
Georg F. W. Scheumann Germany 11 884 0.7× 311 1.0× 602 1.9× 235 0.8× 228 1.1× 19 1.3k
Fernanda Vaisman Brazil 24 1.7k 1.4× 254 0.8× 741 2.4× 358 1.2× 199 1.0× 77 1.9k
Trevor E. Angell United States 27 1.3k 1.1× 647 2.1× 682 2.2× 336 1.2× 229 1.1× 75 2.2k
Keiichi Nakano Japan 19 884 0.7× 248 0.8× 567 1.8× 152 0.5× 365 1.8× 45 1.4k

Countries citing papers authored by Carlotta Giani

Since Specialization
Citations

This map shows the geographic impact of Carlotta Giani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlotta Giani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlotta Giani more than expected).

Fields of papers citing papers by Carlotta Giani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlotta Giani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlotta Giani. The network helps show where Carlotta Giani may publish in the future.

Co-authorship network of co-authors of Carlotta Giani

This figure shows the co-authorship network connecting the top 25 collaborators of Carlotta Giani. A scholar is included among the top collaborators of Carlotta Giani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlotta Giani. Carlotta Giani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barbaro, Daniele, Maria Antonietta Profilo, Paola Lapi, et al.. (2024). Neoadjuvant treatment with lenvatinib and pembrolizumab in a BRAF V600E-mutated anaplastic thyroid cancer: a case report. Frontiers in Endocrinology. 15. 1389294–1389294. 3 indexed citations
2.
Valerio, Laura, Carlotta Giani, Antonio Matrone, et al.. (2023). Adrenal insufficiency in thyroid cancer patients treated with tyrosine kinase inhibitors and detected by ACTH stimulation test. Journal of Endocrinological Investigation. 46(8). 1663–1671. 5 indexed citations
3.
Minaldi, Elisa, Carlotta Giani, Laura Agate, Eleonora Molinaro, & Rossella Elisei. (2023). Pros and cons of an aggressive initial treatment with surgery and radioiodine treatment in minimally invasive follicular thyroid carcinoma. Thyroid Research. 16(1). 2–2. 1 indexed citations
4.
Matrone, Antonio, Alessandro Prete, Alice Nervo, et al.. (2021). Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer. Journal of Endocrinological Investigation. 44(10). 2139–2151. 19 indexed citations
5.
Lorusso, Loredana, Virginia Cappagli, Laura Valerio, et al.. (2021). Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities. International Journal of Molecular Sciences. 22(6). 3117–3117. 47 indexed citations
6.
Valerio, Laura, Carlotta Giani, Laura Agate, et al.. (2021). Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer. European Thyroid Journal. 10(5). 399–407. 30 indexed citations
7.
Prete, Alessandro, Marco Falcone, Valeria Bottici, et al.. (2021). Thyroid cancer and COVID-19: experience at one single thyroid disease referral center. Endocrine. 72(2). 332–339. 5 indexed citations
8.
Giani, Carlotta, Teresa Ramone, Cristina Romei, et al.. (2020). A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion. Case Reports in Endocrinology. 2020(1). 4147097–4147097. 4 indexed citations
9.
Giani, Carlotta, Laura Valerio, Alberto Bongiovanni, et al.. (2020). Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer. Thyroid. 31(2). 224–232. 33 indexed citations
10.
Giani, Carlotta, Liborio Torregrossa, Paolo Piaggi, et al.. (2020). Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up. Endocrine. 68(3). 607–616. 11 indexed citations
11.
Valerio, Laura, Letizia Pieruzzi, Carlotta Giani, et al.. (2017). Targeted Therapy in Thyroid Cancer: State of the Art. Clinical Oncology. 29(5). 316–324. 100 indexed citations
12.
Viola, David, Carlotta Giani, Salvatore Mazzeo, et al.. (2017). KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease. The Journal of Clinical Endocrinology & Metabolism. 102(9). 3091–3096. 2 indexed citations
13.
Matrone, Antonio, Laura Valerio, Letizia Pieruzzi, et al.. (2017). Protein kinase inhibitors for the treatment of advanced and progressive radiorefractory thyroid tumors: From the clinical trials to the real life. Best Practice & Research Clinical Endocrinology & Metabolism. 31(3). 319–334. 27 indexed citations
14.
Viola, David, Laura Valerio, Eleonora Molinaro, et al.. (2016). Treatment of advanced thyroid cancer with targeted therapies: ten years of experience. Endocrine Related Cancer. 23(4). R185–R205. 146 indexed citations
15.
Muller, Ilaria, et al.. (2015). The sodium iodide symporter is unlikely to be a thyroid/breast shared antigen. Journal of Endocrinological Investigation. 39(3). 323–331. 7 indexed citations
16.
Fiore, Emilio, C. Mammoli, Daniela Campani, et al.. (2007). Favorable predictive value of thyroid autoimmunity in high aggressive breast cancer. Journal of Endocrinological Investigation. 30(9). 734–738. 36 indexed citations
17.
Pinchera, Aldo, et al.. (2006). Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. European Journal of Endocrinology. 154(5). 645–649. 62 indexed citations
18.
Fierabracci, Paola, et al.. (2006). Association between breast cancer and autoimmune thyroid disorders: no increase of lymphocytic infiltrates in breast malignant tissues. Journal of Endocrinological Investigation. 29(3). 248–251. 11 indexed citations
19.
Fierabracci, Paola, Aldo Pinchera, Massimo Tonacchera, et al.. (2004). Absence of interference of serum IgGs from patients with breast cancer and thyroid autoimmunity on the function of human iodide symporter gene stably transfected in CHO cells. Journal of Endocrinological Investigation. 27(9). 862–865. 7 indexed citations
20.
Fierabracci, Paola, A Pinchera, P Miccoli, et al.. (2001). Increased prevalence of primary hyperparathyroidism in treated breast cancer. Journal of Endocrinological Investigation. 24(5). 315–320. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junko Akaishi Breakdown of academic impact, for papers by Elham Khanafshar Breakdown of academic impact, for papers by Hyeyeun Lim Breakdown of academic impact, for papers by A.-F. Cailleux Breakdown of academic impact, for papers by Mitsuji Nagahama Breakdown of academic impact, for papers by Daria Handkiewicz-Junak Breakdown of academic impact, for papers by Georg F. W. Scheumann Breakdown of academic impact, for papers by Fernanda Vaisman Breakdown of academic impact, for papers by Trevor E. Angell Breakdown of academic impact, for papers by Keiichi Nakano
Rankless by CCL
2026